Physician profile
Sameer Sharma
NPI 1033278056
$27,153.30
in general payments reported to CMS, 2019-2025
22 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $8,505 · 2021: $17K · 2022: $188 · 2023: $143 · 2024: $941 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $750 · Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $750.00 |
| Food and Beverage | $473.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,141.07 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $149.86 | 2022-2025 | Keytruda, Keytruda Qlex, Welireg |
| Davol INC. | $124.89 | 2024 | Arista Ah Flexitip |
| Glaxosmithkline, LLC. | $104.62 | 2019-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals LP | $99.07 | 2019-2020 | |
| Eisai INC. | $83.52 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.67 | 2020-2025 | |
| Janssen Biotech, INC. | $48.31 | 2023 | |
| Amgen INC. | $45.50 | 2019-2021 | |
| Tesaro, INC. | $34.16 | 2019 | |
| Astellas Pharma US INC | $31.34 | 2019-2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $30.52 | 2024 | Alunbrig |
| Medtronic USA, INC. | $26.95 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.74 | 2021 | |
| Celgene Corporation | $22.55 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $21.19 | 2019 | |
| Jazz Pharmaceuticals INC. | $20.32 | 2019 | |
| Tersera Therapeutics LLC | $19.41 | 2020 | |
| Emd Serono, INC. | $18.11 | 2023 | Tepmetko |
| E.R. Squibb & Sons, L.L.C. | $15.75 | 2020 | |
| Meditrina | $14.04 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.